ATE387187T1 - Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung - Google Patents

Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung

Info

Publication number
ATE387187T1
ATE387187T1 AT01996363T AT01996363T ATE387187T1 AT E387187 T1 ATE387187 T1 AT E387187T1 AT 01996363 T AT01996363 T AT 01996363T AT 01996363 T AT01996363 T AT 01996363T AT E387187 T1 ATE387187 T1 AT E387187T1
Authority
AT
Austria
Prior art keywords
production
active ingredients
core
microgranules
coated
Prior art date
Application number
AT01996363T
Other languages
English (en)
Inventor
Etienne Bruna
Edouard Gendrot
Gerard Cousin
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of ATE387187T1 publication Critical patent/ATE387187T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micromachines (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
AT01996363T 2000-11-16 2001-11-15 Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung ATE387187T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0014803A FR2816507B1 (fr) 2000-11-16 2000-11-16 Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules

Publications (1)

Publication Number Publication Date
ATE387187T1 true ATE387187T1 (de) 2008-03-15

Family

ID=8856551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996363T ATE387187T1 (de) 2000-11-16 2001-11-15 Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung

Country Status (15)

Country Link
US (1) US7829122B2 (de)
EP (1) EP1333812B1 (de)
JP (1) JP4234427B2 (de)
CN (1) CN1222277C (de)
AT (1) ATE387187T1 (de)
AU (2) AU2002223074B2 (de)
CA (1) CA2427899C (de)
DE (1) DE60133028T2 (de)
DK (1) DK1333812T3 (de)
ES (1) ES2300384T3 (de)
FR (1) FR2816507B1 (de)
HK (1) HK1063017A1 (de)
MX (1) MXPA03004300A (de)
PT (1) PT1333812E (de)
WO (1) WO2002039981A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
EP1279402B1 (de) * 2001-07-26 2006-11-29 Ethypharm Umgehüllte Allylamine oder Benzylamine enthaltende Granulate, Verfahren zur Herstellung und in der Mundhöhle dispergierbare Tabletten enthaltend die umgehüllten Granulate
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2850576B1 (fr) * 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
CN103040773A (zh) * 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
JP5607291B2 (ja) 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
CN101912360A (zh) * 2010-07-13 2010-12-15 山东达因海洋生物制药股份有限公司 布洛芬混悬液及其制备方法
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
WO2012109216A1 (en) 2011-02-11 2012-08-16 Zx Pharma, Llc Multiparticulate l-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
CA2909591C (en) 2013-04-23 2017-03-28 Zx Pharma, Llc Enteric coated multiparticulate composition with proteinaceous subcoat
KR102019645B1 (ko) * 2019-02-21 2019-09-09 한국화학연구원 염기성오염물질 제거용 비드 및 이의 제조방법
CN111184694A (zh) * 2020-01-19 2020-05-22 广东青云山药业有限公司 一种口腔速溶颗粒的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
IT1115596B (it) 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
JP3078859B2 (ja) 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
MX9603480A (es) 1994-02-16 1997-12-31 Abbott Lab Procedimiento para preparar formulaciones farmaceuticas en particulas finas.
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
DK1333812T3 (da) 2008-03-31
EP1333812B1 (de) 2008-02-27
CA2427899A1 (fr) 2002-05-23
FR2816507A1 (fr) 2002-05-17
EP1333812A1 (de) 2003-08-13
DE60133028T2 (de) 2009-03-12
DE60133028D1 (de) 2008-04-10
US7829122B2 (en) 2010-11-09
FR2816507B1 (fr) 2003-02-28
US20040101568A1 (en) 2004-05-27
JP4234427B2 (ja) 2009-03-04
CN1222277C (zh) 2005-10-12
JP2004517064A (ja) 2004-06-10
ES2300384T3 (es) 2008-06-16
CN1481235A (zh) 2004-03-10
WO2002039981A1 (fr) 2002-05-23
AU2307402A (en) 2002-05-27
CA2427899C (fr) 2011-05-10
MXPA03004300A (es) 2004-09-10
HK1063017A1 (en) 2004-12-10
PT1333812E (pt) 2008-03-17
AU2002223074B2 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
ATE387187T1 (de) Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung
ATE149835T1 (de) Im magen stabile zusammensetzungen aus omeprazole mikrogranulaten und verfahren zu ihrer herstellung
IL151150A0 (en) Multiparticulate drug form comprising at least two differently coated pellet forms
BR0106912A (pt) Partìculas contendo ingrediente ativo
DE3882461D1 (de) Retroreflektierendes ueberzugsmittel und zusammensetzung zu seiner herstellung.
BG105282A (en) Pharmaceutical oral preparation of a compound having an antifugic activity, and preparation method
WO2002058753A3 (en) Coating for implantable devices and a method of forming the same
DE69510333D1 (de) Synergetische termitizide zusammensetzung aus pyrethroid und n-phenyl-pyrazol
ES2130666T3 (es) Procedimiento de revestimiento de particulas.
DE69930254D1 (de) Mikroströmungstechnischer gebenstand und verfahren zu seiner herstellung
WO2002051363A3 (en) Absorbent articles with simplified compositions having good stability
DE59801636D1 (de) Tantalpulver, verfahren zu seiner herstellung, sowie daraus erhältliche sinteranoden
DE59801634D1 (de) Tantal-pulver, verfahren zu seiner herstellung, sowie daraus erhältliche sinteranoden
DE59903878D1 (de) Aus mindestens drei komponenten bestehendes beschichtungsmittel, verfahren zu seiner herstellung sowie seine verwendung
WO2003035044A3 (de) Herstellung von formkörpern auf basis von stärke-gel
DE3877256D1 (de) Beschichteter gegenstand und verfahren zu seiner herstellung.
DE59904493D1 (de) Aus mindestens drei komponenten bestehendes beschichtungsmittel, verfahren zu seiner herstellung sowie seine verwendung
WO1999050430A3 (en) Modification of fatty acid composition in plants by expression of an aspergillus nidulans delta-9 coa desaturase
DE59708634D1 (de) Elektro-keramisches bauelement und verfahren zu seiner herstellung
DE69114697D1 (de) Zeolith vom mfi-typ sowie verfahren zu seiner herstellung.
DE69623599D1 (de) Verfahren zur herstellung von granulaten und danach hergestellte granulate
DE69414488D1 (de) Gesintertes Kontaktbauteil, sowie Verfahren seiner Herstellung
DE69827599D1 (de) Schuh und verfahren zu seiner herstellung
WO2002080706A3 (en) Improved delivery of benefit agents
DE69806093D1 (de) Maske zur Herstellung von laminierten dreidimensionalen Gegenstände, sowie dessen Herstellungs- und Gebrauchsverfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1333812

Country of ref document: EP